Inventor

ERGUEDEN JENS-KERIM

DE12 patents

⚠️ This page may combine multiple inventors who share the name “ERGUEDEN JENS-KERIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THEDE KAI

4 patents

US8653111B2Feb 18, 2014

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

THEDE KAI7 citations83

US8389520B2Mar 5, 2013

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

THEDE KAI8 citations83

US8524699B2Sep 3, 2013

Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors

THEDE KAI6 citations72

US8609698B2Dec 17, 2013

Substituted dipyridyl-dihydropyrazolones and use thereof

THEDE KAI4 citations61

BAYER HEALTHCARE AG

2 patents

US6936609B2Aug 30, 2005

Imidazotriazines for use as phosphodiesterase inhibitors

BAYER HEALTHCARE AG17 citations82

US7045544B2May 16, 2006

Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases

BAYER HEALTHCARE AG6 citations61

BAYER AG

1 patent

US6589949B1Jul 8, 2003

3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases

BAYER AG23 citations91

FLAMME INGO

1 patent

US8252817B2Aug 28, 2012

Dipyridyl-dihydropyrazolones and their use

FLAMME INGO7 citations81

BAYER PHARMACEUTICALS CORP

1 patent

US6930114B2Aug 16, 2005

Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors

BAYER PHARMACEUTICALS CORP19 citations81

BAYER SCHERING PHARMA AG

1 patent

US7989633B2Aug 2, 2011

4-Chromenonyl-1,4-dihydropyridines and their use

BAYER SCHERING PHARMA AG2 citations61

KUHL ALEXANDER

1 patent

US8058447B2Nov 15, 2011

4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof

KUHL ALEXANDER2 citations57

ERGUEDEN JENS-KERIM

1 patent

US8691850B2Apr 8, 2014

Substituted phenylaminothiazoles and use thereof

ERGUEDEN JENS-KERIM0 citations33